rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Daniel H. Schneiderman

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, Pasithea Therapeutics; Chief Financial Officer, GridAI Technologies; VP of Finance and Secretary, MetaStat.

In numbers

Trades disclosed
25
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
3
Companies where not an officer
0
First trade
5 Apr 2013
Last trade
1 May 2026
Last filed
5 May 2026

Companies traded

Where they are an officer
KTTA Pasithea TherapeuticsOfficer · Biotechnology · last 1 May 20260 buys · 0 sells
GRDX GridAI TechnologiesOfficer · Electric Utilities & IPPs · last 3 Jan 20220 buys · 0 sells
MetaStatOfficer · last 12 Jan 20180 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
1 May 2026filed 5 May 2026KTTA Pasithea Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—1,129,323 at $0.00filing
1 May 2026filed 5 May 2026KTTA Pasithea Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—1,129,323 at $0.00filing
28 Nov 2025filed 1 Dec 2025KTTA Pasithea TherapeuticsBiotechnologySEC FORM 4 Code A$20K26,667 at $0.75filing
24 Oct 2025filed 27 Oct 2025KTTA Pasithea Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—317,266 at $0.00filing
1 Mar 2024filed 5 Apr 2024KTTA Pasithea Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
1 Mar 2024filed 5 Apr 2024KTTA Pasithea Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—5,927 at $0.00filing
1 Mar 2024filed 1 Mar 2024KTTA Pasithea Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
1 Mar 2024filed 1 Mar 2024KTTA Pasithea Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—5,927 at $0.00filing
11 Oct 2022filed 12 Oct 2022KTTA Pasithea Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—300,000 at $0.00filing
3 Jan 2022filed 3 Jan 2022GRDX GridAI Technologiesoption or derivative · Electric Utilities & IPPsSEC FORM 4 Code A—10,000 at $0.00filing
30 Jun 2021filed 2 Jul 2021GRDX GridAI Technologiesoption or derivative · Electric Utilities & IPPsSEC FORM 4 Code J—35,006 at $0.00filing
30 Jun 2021filed 2 Jul 2021GRDX GridAI Technologiesoption or derivative · Electric Utilities & IPPsSEC FORM 4 Code A—35,006 at $0.00filing
30 Jun 2021filed 2 Jul 2021GRDX GridAI Technologiesoption or derivative · Electric Utilities & IPPsSEC FORM 4 Code J—250,000 at $0.00filing
30 Jun 2021filed 2 Jul 2021GRDX GridAI Technologiesoption or derivative · Electric Utilities & IPPsSEC FORM 4 Code A—250,000 at $0.00filing
16 Jul 2020filed 20 Jul 2020GRDX GridAI Technologiesoption or derivative · Electric Utilities & IPPsSEC FORM 4 Code J—35,006 at $0.00filing
16 Jul 2020filed 20 Jul 2020GRDX GridAI Technologiesoption or derivative · Electric Utilities & IPPsSEC FORM 4 Code A—35,006 at $0.00filing
16 Jul 2020filed 20 Jul 2020GRDX GridAI Technologiesoption or derivative · Electric Utilities & IPPsSEC FORM 4 Code A—250,000 at $0.00filing
2 Jan 2020filed 9 Jan 2020GRDX GridAI Technologiesoption or derivative · Electric Utilities & IPPsSEC FORM 4 Code A—335,006filing
12 Jan 2018filed 17 Jan 2018MetaStatoption or derivativeSEC FORM 4 Code J$72K76,962 at $0.93filing
4 Apr 2017filed 6 Apr 2017MetaStatoption or derivativeSEC FORM 4 Code J$75K25,000 at $3.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Jason David SawyerChief Executive Officer · Chief Executive Officer at GridAI Technologies, filing Form 4 there in the last year
Coastlands Capital LP10% owner · 10% owner at Pasithea Therapeutics, filing Form 4 there in the last year
Jack SyageDirector · Director at GridAI Technologies, filing Form 4 there in the last year
Tiago MarquesChief Executive Officer · Chief Executive Officer at Pasithea Therapeutics, filing Form 4 there in the last year
Simon DumesnilDirector · Director at Pasithea Therapeutics, filing Form 4 there in the last year